Valaciclovir

Valaciclovir

Form: Tablet

Strength: 500 mg, 1000 mg (1 g)

Reference Brands: Valtrex(US)

Category: Anti Viral

Valtrex (Valaciclovir) is a widely used antiviral medication for treating herpes infections, including cold sores, genital herpes, and shingles. On PharmaB2B platforms, Valtrex is available in bulk supply for B2B trade, connecting pharmaceutical distributors, exporters, and healthcare providers with verified manufacturers. PharmaB2B simplifies sourcing of Valaciclovir tablets in various strengths like 500 mg and 1000 mg, ensuring regulatory compliance and competitive pricing. Whether you're seeking WHO-GMP, USFDA, or EU-GMP certified suppliers, PharmaB2B helps streamline procurement of Valtrex for both domestic and international markets. Boost your pharmaceutical sourcing strategy with quality-assured Valaciclovir through a trusted PharmaB2B network.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Zanamivir

Strength: 5 mg/blister

Form: Inhalation powder

Reference Brands: Relenza(EU & US)

View Details Get Enquiry
Oseltamivir Phosphate Capsule

Strength: Capsule- 30 mg, 45 mg, 75 mg; Oral Suspension - 6 mg/mL (reconstituted)

Form: Capsules and Oral solution

Reference Brands: Tamiflu(EU & US)

View Details Get Enquiry
Amantadine

Strength: Tab -100 mg; Capsule- 100 mg; Oral solution - 50 mg/5 mL; Extended-release capsule (ER) - 129 mg, 193 mg

Form: Tablet; Capsule; Oral Solution and ER Capsule

Reference Brands: Symmetrel(EU & US); Osmolex ER(US), Gocovri(US)

View Details Get Enquiry
Glecaprevir + Pibrentasvir

Strength: Glecaprevir- 100 mg + Pibrentasvir - 40 mg

Form: Tablet

Reference Brands: Mavyret (US); Maviret (EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.